BackBenitec Biopharma Overview

Benitec Biopharma Other Current Assets

Track Benitec Biopharma's other current assets ($1.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$1.26M
194.15% YoYΔ $829000.00 vs prior year quarter

Peer average / median

Loading

Benitec Biopharma Other Current Assets History

Loading

Benitec Biopharma vs. peers: Other Current Assets Comparison

Loading

Benitec Biopharma Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Benitec Biopharma (BNTC) FAQ

As of the most recent data (March 2026), BNTC shows a other current assets of $1.3M. That compares with $430K in the prior-year period — up 194.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BNTC's other current assets is now $1.3M (was $430K) — a 194.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Benitec Biopharma is outperforming or lagging.

Tracking BNTC's other current assets over time shows whether Benitec Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3M That compares with $430K in the prior-year period — up 194.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Benitec Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $1.3M) with ownership activity and broader fundamentals.